Driftstatus

Nyheter i Janusmed

Janusmed

Driftstatus

Nyheter i Janusmed

Driftstörning i Janusmed interaktioner
Funktionen att visa samtliga interaktioner för en substans fungerar för närvarande inte vid sökning på vissa produkter. Se mer under driftstatus
sotalol, Cordarone (Injektionsvätska, lösning)
  • sotalol
  • Cordarone (Injektionsvätska, lösning)
Rensa sökning

4/5/2026

Janusmed interaktioner

Interaktioner

Startsida interaktioner

Aktuellt

Användarhandledning

E-utbildning

CYP3A4-hämmare/inducerare

FAQ

Skriv ut

Administreringssätt

Skriv ut

1 interaktion mellan valda läkemedel
Lägg till
Rensa tillval
Läkemedel / substans
Interaktioner
Cordarone (Injektionsvätska, lösning)
amiodaron (Parenteral)

256

sotalol (Enteral och parenteral)

189

D2 D2
D2 D2

amiodaron - sotalol

amiodaron - sotalol

Klass : D2

Visa all info

Skriv ut

Kontakta oss

  1. Stocley IH. Drug Interactions. London: The Pharmaceutical Press. (Edition expires [10/2004]).

  2. Derrida JP, Ollagnier J, Benaim R, Haiat R, Chiche P. [Amiodarone and propanolol: a dangerous combination?]. Nouv Presse Med. 1979;8:1429.

  3. Leor J, Levartowsky D, Sharon C, Farfel Z. Amiodarone and beta-adrenergic blockers: an interaction with metoprolol but not with atenolol. Am Heart J. 1988;116:206-7.

  4. Boutitie F, Boissel JP, Connolly SJ, Camm AJ, Cairns JA, Julian DG et al. Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators. Circulation. 1999;99:2268-75.

  5. Krum H, Shusterman N, MacMahon S, Sharpe N. Efficacy and safety of carvedilol in patients with chronic heart failure receiving concomitant amiodarone therapy. Australia/New Zealand Heart Failure Research Collaborative Group. J Card Fail. 1998;4:281-8.

  6. Warren R, Vohra J, Hunt D, Hamer A. Serious interactions of sotalol with amiodarone and flecainide. Med J Aust. 1990;152:277.

  7. Wolbrette DL. Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues. Am J Cardiol. 2003;91:39D-44D.

  1. Stocley IH. Drug Interactions. London: The Pharmaceutical Press. (Edition expires [10/2004]).
  2. Derrida JP, Ollagnier J, Benaim R, Haiat R, Chiche P. [Amiodarone and propanolol: a dangerous combination?]. Nouv Presse Med. 1979;8:1429.
  3. Leor J, Levartowsky D, Sharon C, Farfel Z. Amiodarone and beta-adrenergic blockers: an interaction with metoprolol but not with atenolol. Am Heart J. 1988;116:206-7.
  4. Boutitie F, Boissel JP, Connolly SJ, Camm AJ, Cairns JA, Julian DG et al. Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators. Circulation. 1999;99:2268-75.
  5. Krum H, Shusterman N, MacMahon S, Sharpe N. Efficacy and safety of carvedilol in patients with chronic heart failure receiving concomitant amiodarone therapy. Australia/New Zealand Heart Failure Research Collaborative Group. J Card Fail. 1998;4:281-8.
  6. Warren R, Vohra J, Hunt D, Hamer A. Serious interactions of sotalol with amiodarone and flecainide. Med J Aust. 1990;152:277.
  7. Wolbrette DL. Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues. Am J Cardiol. 2003;91:39D-44D.